AIM IMMUNOTECH INC. Payments of Debt Issuance Costs
AIM IMMUNOTECH INC. (AIM) reported Payments of Debt Issuance Costs of $439.00 thousand for the 12-month period ending 2018-12-31, per its 10-K filed 2020-03-30.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsOfDebtIssuanceCosts · last filed 2020-03-30
- AIM IMMUNOTECH INC. payments of debt issuance costs for the quarter ending 2018-12-31 was -$59.00K, a 591.67% decline year-over-year.
- AIM IMMUNOTECH INC. payments of debt issuance costs for the quarter ending 2018-09-30 was $230.00K, a 22900.00% increase year-over-year.
- AIM IMMUNOTECH INC. payments of debt issuance costs for the quarter ending 2018-06-30 was $0.00.
- AIM IMMUNOTECH INC. payments of debt issuance costs for the quarter ending 2018-03-31 was $268.00K.
- AIM IMMUNOTECH INC. payments of debt issuance costs for fiscal 2018 was $439.00K, a 330.39% increase from fiscal 2017.
- AIM IMMUNOTECH INC. payments of debt issuance costs for fiscal 2017 was $102.00K.
| Period end | Payments of Debt Issuance Costs 3 month | Payments of Debt Issuance Costs 6 month | Payments of Debt Issuance Costs 9 month | Payments of Debt Issuance Costs 12 month |
|---|---|---|---|---|
| 2018-12-31 | -$59.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30 | $171.00K derived: sum of 2 quarters · filed 2020-03-30 | $171.00K derived: sum of 3 quarters · filed 2020-03-30 | $439.00K 10-K · filed 2020-03-30 |
| 2018-09-30 | $230.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | $230.00K derived: sum of 2 quarters · filed 2019-11-14 | $498.00K 10-Q · filed 2019-11-14 | $510.00K derived: sum of 4 quarters · filed 2019-11-14 |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | $268.00K 10-Q · filed 2019-08-14 | $280.00K derived: sum of 3 quarters · filed 2019-08-14 | $281.00K derived: sum of 4 quarters · filed 2019-08-14 |
| 2018-03-31 | $268.00K 10-Q · filed 2019-05-15 | $280.00K derived: sum of 2 quarters · filed 2019-05-15 | $281.00K derived: sum of 3 quarters · filed 2019-05-15 | |
| 2017-12-31 | $12.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-01 | $13.00K derived: sum of 2 quarters · filed 2019-04-01 | $102.00K 10-K · filed 2019-04-01 | |
| 2017-09-30 | $1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-14 | $90.00K 10-Q · filed 2017-11-14 | ||
| 2017-06-30 | $89.00K 10-Q · filed 2018-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |